Adenoviral-mediated gene therapy for thyroid carcinoma using thymidine kinase controlled by thyroglobulin promoter demonstrates high specificity and low toxicity (Q40715150)
Jump to navigation
Jump to search
scientific article published on February 2001
Language | Label | Description | Also known as |
---|---|---|---|
English | Adenoviral-mediated gene therapy for thyroid carcinoma using thymidine kinase controlled by thyroglobulin promoter demonstrates high specificity and low toxicity |
scientific article published on February 2001 |
Statements
1 reference
Adenoviral-mediated gene therapy for thyroid carcinoma using thymidine kinase controlled by thyroglobulin promoter demonstrates high specificity and low toxicity (English)
1 reference
Zhang R
1 reference
Straus FH
1 reference
DeGroot LJ
1 reference
1 February 2001
1 reference
1 reference
11
1 reference
2
1 reference
115-123
1 reference
Identifiers
1 reference
1 reference